FDA
-
-
-
-
-
-
-
Lupin Announces Approval of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the United States
-
-
-
-
-
-
-
Lupin launches partnership program for long-acting injectable platform
-
-
-
-
-
-
-
Lupin Presents Phase 3 Data for SolosecĀ® (secnidazole) Demonstrating Significant Response Rate in Female Patients with Trichomoniasis
-
-
-
328,710 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

